Protective effects of luteolin against cognitive impairment induced by infusion of Aβ peptide in rats

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 6, 2015, Pages 6740-6747

  Yu, Tian Xia ^a   Zhang, Peng ^b   Guan, Yan ^c   Wang, Min ^a   Zhen, Ming Qing ^b  

^a YANTAISHAN HOSPITAL   (China)

^b Department of Blood Purification Centre   (China)

^c SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Alzheimer's disease; Antioxidant activity; A peptide; Luteolin; Neuroprotection

Indexed keywords

ACETYLCHOLINESTERASE; ACHE PROTEIN, RAT; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; ANTIOXIDANT; BAX PROTEIN, RAT; CHOLINE ACETYLTRANSFERASE; GLUTATHIONE PEROXIDASE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; LUTEOLIN; MALONALDEHYDE; NEUROPROTECTIVE AGENT; PEPTIDE FRAGMENT; PROTEIN BAX; PROTEIN BCL 2; SUPEROXIDE DISMUTASE;

ANIMAL; ANIMAL BEHAVIOR; CHEMICALLY INDUCED; COGNITION; COGNITION DISORDERS; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; HIPPOCAMPUS; MAZE TEST; MEMORY; METABOLISM; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PSYCHOLOGY; SPRAGUE DAWLEY RAT;

ACETYLCHOLINESTERASE; AMYLOID BETA-PEPTIDES; ANIMALS; ANTIOXIDANTS; BCL-2-ASSOCIATED X PROTEIN; BEHAVIOR, ANIMAL; CHOLINE O-ACETYLTRANSFERASE; COGNITION; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTATHIONE PEROXIDASE; GPI-LINKED PROTEINS; HIPPOCAMPUS; LUTEOLIN; MALONDIALDEHYDE; MAZE LEARNING; MEMORY; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE;

EID: 84938651959     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Selkoe DJ. The molecular pathology of Alzheimer's disease. Neuron 1991; 6: 487-498.
2. Hashimoto M, Hossain S, Shimada T, Sugioka K, Yamasaki H, Fujii Y, Ishibashi Y, Oka J, Shido O. Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats. J Neurochem 2002; 81: 1084-1091.
3. Hashimoto M, Tanabe Y, Fujii Y, Kikuta T, Shibata H, Shido O. Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid beta-infused rats. J Nutr 2005; 135: 549-555.
4. Jakob-Roetne R, Jacobsen H. Alzheimer's disease: from pathology to therapeutic approaches. Angew Chem Int Ed Engl 2009; 48: 3030-3059.
5. Ruan CJ, Li Z, Zhang L, Chen DH, Du GH, Sun L. Protective effects of trans-2,4-dimethoxysti-bene on cognitive, impairments induced by Aβ25-35 in hypercholesterolemic rats. Brain Res. Bull 2010; 82: 251-258.
6. Choi J, Levey AI, Weintraub ST, Rees HD, Gearing M, Chin LS, Li L. Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases. J Biol Chem 2004; 279: 13256-13264.
7. Floyd RA. Antioxidants, oxidative stress and degenerative neurological disorders. Proc Soc Exp Biol Med 1999; 222: 236-245.
8. Sultana R, Newman S, Mohmmad-Abdul H, Keller JN, Butterfield DA. Protective effect of the xanthate, D609, on Alzheimer's amyloid betapeptide (1-42)-induced oxidative stress in primary neuronal cells. Free Radical Res 2004; 38: 449-458.
9. Choi SJ, Kim MJ, Heo HJ, Hong B, Cho HY, Kim YJ, Kim HK, Lim ST, Jun WJ, Kim EK, Shin DH. Ameliorating effect of Gardenia jasminoides extract on amyloid beta peptide-induced neuronal cell deficit. Mol Cells 2007; 24: 113-118.
10. Zhang HY, Liu YH, Wang HQ, Xu JH, Hu HT. Puerarin protects PC12 cells against beta-amyloid-induced cell injury. Cell Biol Int 2008; 32: 1230-1237.
11. Bagheri M, Joghataei MT, Mohseni S, Roghani M. Genistein ameliorates learning and memory deficits in amyloid β (1-40) rat model of Alzheimer's disease. Neurobiol. Learn Mem 2011; 95: 270-276.
12. Pandurangan AK, Dharmalingam P, Ananda Sadagopan SK, Ganapasam S. Effect of luteolin on the levels of glycoproteins during azoxymethane-induced colon carcinogenesis in mice. Asian Pac J Cancer Prev 2012; 13: 1569-1573.
13. Jung HA, Jin SE, Min BS, Kim BW, Choi JS. Anti-inflammatory activity of Korean thistle Cirsium maackii and its major flavonoid, luteolin 5-O-glucoside. Food Chem Toxicol 2012; 50: 2171-2179.
14. Manju V, Nalini N. Protective role of luteolin in 1,2-dimethylhydrazine induced experimental colon carcinogenesis. Cell Biochem Funct 2007; 25: 189-194.
15. Sun GB, Sun X, Wang M, Ye JX, Si JY, Xu HB, Meng XB, Qin M, Sun J, Wang HW, Sun XB. Oxidative stress suppression by luteolin-induced heme oxygenase-1 expression. Toxicol Appl Pharmacol 2012; 265: 229-240.
16. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 2002; 416: 535-539.
17. Malaplate-Armand C, Florent-Béchard S, Youssef I, Koziel V, Sponne I, Kriem B, Leininger-Muller B, Olivier JL, Oster T, Pillot T. Soluble oligomers of amyloid-beta peptide in duce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway. Neurobiol Dis 2006; 23: 178-189.
18. Vieira MN, Forny-Germano L, Saraiva LM, Sebollela A, Martinez AM, Houzel JC, De Felice FG, Ferreira ST. Soluble oligomers from a non-disease related protein mimic Abeta-induced tau hyperphosphorylation and neurodegeneration. J Neurochem 2007; 103: 736-748.
19. Zheng MQ, Yin DZ, Zhang L, Lei B, Cheng DF, Cai HC, Han YJ, Wu MX, Zhang H, Wang J. Biological characters of [F-18]O-FEt-PIB in a rat model of Alzheimer's disease using micro-PET imaging. Acta Pharmacol Sin 2008; 29: 548-554.
20. Han M, Liu Y, Tan Q, Zhang B, Wang W, Liu J, Zhang XJ, Wang YY, Zhang JM. Therapeutic efficacy of stemazole in a beta-amyloid injection rat model of Alzheimer's disease. Eur J Pharmacol 2011; 657: 104-110.
21. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984; 11: 47-60.
22. Bagheri M, Joghataei MT, Mohseni S, Roghani M. Genistein ameliorates learning and memory deficits in amyloid (1-40) rat model of Alzheimer's disease. Neurobiol Learn Mem 2011; 95: 270-276.
23. Kar S, Quirion R. Amyloid beta peptides and central cholinergic neurons: functional interrelationship and relevance to Alzheimer's disease pathology. Prog Brain Res 2004; 145: 261-274.
24. Yamaguchi Y, Miyashita H, Tsunekawa H, Mouri A, Kim HC, Saito K, Matsuno T, Kawashima S, Nabeshima T. Effects of a novel cognitive enhancer, spiro [imidazo-[1,2-a]pyridine-3,2-indan]-2 (3H)-one (ZSET1446), on learning impairments induced by amyloid-beta1-40 in the rat. J Pharmacol Exp Ther 2006; 317: 1079-1087.
25. Reddy PH. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease. J Neurochem 2006; 96: 1-13.
26. Anderson AJ, Su JH, Cotman CW. DNA damage and apoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area and effect of postmortem delay. J Neurosci 1996; 16: 1710-1719.
27. Gervais FG, Xu D, Robertson GS, Vaillancourt JP, Zhu Y, Huang J, LeBlanc A, Smith D, Rigby M, Shearman MS, Clarke EE, Zheng H, Van Der Ploeg LH, Ruffolo SC, Thornberry NA, Xanthoudakis S, Zamboni RJ, Roy S, Nicholson DW. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell 1999; 97: 395-406.
28. Misao J, Hayakawa Y, Ohno M, Kato S, Fujiwara T, Fujiwara H. Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction. Circulation 1996; 94: 1506-1512.
29. Wang R, Zhang HY, Tang XC. Huperzine A attenuates cognitive dysfunction and neuronal degeneration caused by betaamyloidprotein-(1-40) in rat. Eur J Pharmacol 2001; 421: 149-156.